X

Johnson & Johnson (JNJ) Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release

Newsdesk: